Relative Survival, Conditional Survival, and Causes of Death in Patients with Early Gastric Cancer, with a Focus on Differences Between Cardia and Non-Cardia Cancer
2024

Survival and Causes of Death in Early Gastric Cancer

Sample size: 9721 publication 10 minutes Evidence: high

Author Information

Author(s): Elgenidy Anas, Alomari Omar, Hesn Mohamed Marey, Khaled Anas, Nada Sarah A., Elsayed Mostafa, Mahmoud Ali, Al-kurdi Mohammed Al-mahdi, Afifi Ahmed M., Cholankeril George

Primary Institution: Cairo University

Hypothesis

This study aims to investigate the causes of death and survival rates among early gastric cancer patients, focusing on differences between cardia and non-cardia cancer.

Conclusion

The study highlights the significant impact of non-cancer causes of death in gastric cancer patients and emphasizes the need for considering comorbidities in their management.

Supporting Evidence

  • The study analyzed data from 9721 patients diagnosed with early gastric cancer.
  • The 1-year and 5-year relative survival rates for CGC patients were 76.4% and 48.9%, respectively.
  • Non-cancer causes of death were significant, with cardiovascular diseases being the most common.

Takeaway

This study looked at patients with early stomach cancer and found that many died from causes other than cancer, showing that doctors need to pay attention to other health issues too.

Methodology

The study used SEER*stat software to analyze data from the SEER 17 plus dataset (2000–2019) and calculated standardized mortality ratios, relative survival, and conditional survival.

Potential Biases

Potential coding errors and the quality of medical registrars documenting causes of death may affect the results.

Limitations

The study did not include patient-specific risk factors and relied on retrospective data, which may introduce bias.

Participant Demographics

The majority of patients were aged over 65, predominantly white, and included a significant number of males.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI (75–77.7) for 1-year relative survival in CGC patients

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cancers16244262

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication